Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.2%

1 terminated out of 24 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed with results

Key Signals

4 with results92% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (11)
P 1 (2)
P 2 (1)
P 3 (2)
P 4 (2)

Trial Status

Completed11
Unknown4
Recruiting3
Not Yet Recruiting3
Withdrawn2
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT04621929Phase 3Completed

Phentermine/Topiramate for Uric Acid Stones

NCT04916314Not ApplicableCompletedPrimary

REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes

NCT05277558Recruiting

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

NCT05838287Phase 4RecruitingPrimary

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

NCT04931836Not ApplicableCompleted

The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults

NCT06682481Recruiting

Beta-Cell - Liver Interactions in Situations of Modified Beta-Cell Function

NCT06643806Not ApplicableNot Yet Recruiting

Implementation of a Peer Leader-facilitated Dyadic Intervention

NCT06497595Not ApplicableNot Yet RecruitingPrimary

Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide

NCT06442150Not ApplicableNot Yet RecruitingPrimary

LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences

NCT05409027Phase 1CompletedPrimary

A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62

NCT05770076Not ApplicableCompleted

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)

NCT04741074Phase 3Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

NCT06223490Not ApplicableUnknownPrimary

Effect of Cryolipolysis on Insulin Resistance

NCT05890950Phase 1Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

NCT05072990CompletedPrimary

Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine

NCT06005012Phase 2Unknown

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

NCT04910997Not ApplicableWithdrawn

Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes

NCT05606471Phase 4UnknownPrimary

Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets

NCT05446415Not ApplicableUnknown

L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

NCT04303819CompletedPrimary

The Effect of Exenatide on Fasting Bile Acids

Scroll to load more

Research Network

Activity Timeline